OGN
NYSE Organon & Co.$13.79 ↑ +0.00 (+0.00%) Trading Up from the previous close of $13.79
- YTD change
- +92.33%
- vs 20-day SMA
- +0.65%
- vs 200-day SMA
- +25.46%
Price ranges
Price & Performance
+7.93 (+135.32%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 65.1% away from all-time highs of $39.48
- OGN is up 92% since the beginning of the year
- OGN is up 35% over the past 12 months
- OGN is up 1% over the past 1 month
- 7% of all OGN investors are betting against OGN
- Number of investors short OGN has gone up 5% versus last month
OGN reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +34.7%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +0.66%
- vs 8-day SMA
- +0.45%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
